• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

sharon.lewin@unimelb.edu.au

Credentials


Position
Director, Peter Doherty Institute
Department of Infectious Diseases
Education
PhD
Monash University
Bachelors Degree
Monash University
ORCID

0000-0002-0330-8241

Prof Sharon Lewin

Director, Peter Doherty Institute
Department of Infectious Diseases

622 Scholarly works
168 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Targeting rapidly cycling receptors CD2 and CD7 increases nanoparticle delivery to primary CD4 T cells.
    DOI: 10.1038/s41467-026-74981-2
  • 2026

    Research contracts (non-grants)

    Doherty Institute Strategic Partnership for Prevention, Surveillance and Response to Infectious Diseases Across the Indo-Pacific Region
  • 2026

    Journal article

    Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research Trials
    DOI: 10.1016/S2352-3018(25)00373-X
  • 2026

    Journal article

    Methaneseleninic acid, a circadian-modulating agent, reactivates latent HIV-1 infection without cellular activation or proliferation
    DOI: 10.1128/jvi.01983-25
  • 2026

    Journal article

    Integrating HIV services in an era of global change
    DOI: 10.1002/jia2.70087
  • 2024

    Research contracts (non-grants)

    UoM-Bonn Collaborative Research Agreement for the Cumming Global Centre for Pandemic Therapeutics
  • 2019

    Research Grant

    Addressing the Major Challenges in Hiv Vaccine and Cure Research
Sharon Lewin

Latest Honours,
Awards and Fellowships


2029
Reappointment. Expires 02/09/2029 University of Melbourne
2020
Melbourne Laureate Professor - Appointment Expires on 11/05/2025 University of Melbourne
2019
2014
Melburnian of the Year 2014

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Innate antiviral and immune functions associated with the HIV reservoir decay after anti-PD-1 therapy
    DOI: 10.1038/s41591-025-04139-y
  • 2026

    Journal article

    Kinetics and Predictors of Hepatitis B Surface Antigen Loss After Commencing Hepatitis B Virus (HBV)–Active Antiretroviral Therapy in the Setting of HIV and Chronic HBV Coinfection
    DOI: 10.1093/cid/ciaf281
  • 2026

    Journal article

    The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir
    DOI: 10.1371/journal.ppat.1013923
  • 2026

    Journal article

    Immunotherapy and impact on tissue reservoirs
    DOI: 10.1097/COH.0000000000000996
  • 2026

    Journal article

    Use of HIV Phylogenetic Analysis in Public Health in Victoria, Australia: Regulatory Considerations
    DOI: 10.1007/s11673-025-10496-7
  • 2026

    Journal article

    Analytical treatment interruption as a tool in the evaluation of immune-mediated interventions for long-term antiretroviral-free control of HIV-1 among people with HIV
    DOI: 10.1016/j.cct.2025.108144

RECENT PROJECTS

  • 2023

    Research contracts (non-grants)

    REVEAL (Alfred MACH)
  • 2025

    Research grants (international)

    Direct and Indirect Targeting of HIV Tat for Selective RNA Degradation and Protein Suppression

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224